Cardiac Arrhythmias Clinical Trials

8 recruitingLast updated: June 18, 2026

There are 8 actively recruiting cardiac arrhythmias clinical trials across 7 countries. Studies span Phase 4. Top locations include Philadelphia, Pennsylvania, United States, La Jolla, California, United States, Barcelona, Barcelona, Spain. Updated daily from ClinicalTrials.gov.


Cardiac Arrhythmias Trials at a Glance

8 actively recruiting trials for cardiac arrhythmias are listed on ClinicalTrialsFinder across 6 cities in 7 countries. The largest study group is Phase 4 with 1 trial, with the heaviest enrollment activity in Philadelphia, La Jolla, and Barcelona. Lead sponsors running cardiac arrhythmias studies include Elutia Inc., Idoven 1903 S.L., and Abbott Medical Devices.

Browse cardiac arrhythmias trials by phase

About Cardiac Arrhythmias Clinical Trials

Looking for clinical trials for Cardiac Arrhythmias? There are currently 9 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Cardiac Arrhythmias trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Cardiac Arrhythmias clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 18 of 8 trials

Recruiting
Phase 4

The Clinical Outcomes and Therapeutic Effects in Patients With Cardiac Implantable Electronic Device-detected Subclinical and Clinical Atrial Fibrillation.

Subclinical Atrial FibrillationCardiac Arrhythmias
National Taiwan University Hospital450 enrolled1 locationNCT07649109
Recruiting

Observational Study of Cardiac Arrhythmias During Treatment With BTK Inhibitors or Venetoclax

Mantle Cell LymphomaSudden Cardiac DeathChronic Lymphocytic Leukemia (CLL)+3 more
National Heart, Lung, and Blood Institute (NHLBI)135 enrolled1 locationNCT05724121
Recruiting

ViewFlex X ICE First-in-Human Study

Cardiac Arrhythmias
Abbott Medical Devices500 enrolled8 locationsNCT06772493
Recruiting

AI-powered ECG Analysis Using Willem™ Software in High-risk Cardiac Patients (WILLEM)

CardiomyopathiesSudden Cardiac DeathCardiac Arrest+1 more
Idoven 1903 S.L.5,342 enrolled14 locationsNCT05890716
Recruiting

EluPro Antibiotic-Eluting BioEnvelope Registry

Cardiac Arrhythmias
Elutia Inc.100 enrolled4 locationsNCT06854081
Recruiting

Bad Berka Heart Rhythm Registry of Patients With or at Risk of Arrhythmias Treated at Heart Center Bad Berka

Cardiac Arrhythmias
Zentralklinik Bad Berka5,000 enrolled1 locationNCT07020910
Recruiting

Utility of Gene Test Analysis for Diagnosis, Prognosis and Treatment of Patients With Genetic Arrhythmic Heart Disease: the ARRHYTHMIC GENE-HEART

CardiologyGenetic DiseaseCardiac Disease+2 more
University Hospital of Ferrara200 enrolled1 locationNCT06898307
Recruiting

Japanese Catheter Ablation Registry

Catheter AblationCardiac Arrhythmias
National Cerebral and Cardiovascular Center, Japan400,000 enrolled1 locationNCT03729232